CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
MMP12 |
P39900
|
matrix metallopeptidase 12
|
Enzyme
|
|
0.484 |
0.885 |
COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
PECAM1 |
P16284
|
platelet and endothelial cell adhesion molecule 1
|
Cell adhesion
|
|
0.426 |
0.846 |
RNASE2 |
P10153
|
ribonuclease A family member 2
|
|
|
0.621 |
0.692 |
RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
ST2 |
|
suppression of tumorigenicity 2
|
|
|
0.576 |
0.692 |
TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
TUG1 |
|
taurine up-regulated 1
|
|
|
0.522 |
0.769 |
TTC25 |
Q96NG3
|
tetratricopeptide repeat domain 25
|
|
|
0.674 |
0.538 |
HSH2D |
Q96JZ2
|
hematopoietic SH2 domain containing
|
|
|
0.722 |
0.462 |
HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
MALAT1 |
|
metastasis associated lung adenocarcinoma transcript 1
|
|
|
0.435 |
0.846 |
MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
MIR17 |
|
microRNA 17
|
|
|
0.459 |
0.846 |